Abpro Bio Co., Ltd. (KOSDAQ:195990)
South Korea
· Delayed Price · Currency is KRW 310.00
-1.00 (-0.32%)
Last updated: Apr 1, 2025
Abpro Bio Revenue
In the year 2024, Abpro Bio had annual revenue of 31.66B KRW with 24.78% growth. Abpro Bio had revenue of 10.32B in the quarter ending December 31, 2024, with 69.90% growth.
Revenue
31.66B
Revenue Growth
+24.78%
P/S Ratio
2.74
Revenue / Employee
620.84M
Employees
51
Market Cap
86.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31.66B | 6.29B | 24.78% |
| Dec 31, 2023 | 25.38B | 3.26B | 14.76% |
| Dec 31, 2022 | 22.11B | -10.80B | -32.82% |
| Dec 31, 2021 | 32.91B | -2.88B | -8.05% |
| Dec 31, 2020 | 35.80B | 3.87B | 12.11% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |